- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01206166
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP) (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
The specific aim of the proposed study is to conduct a pilot study involving 160 critically-ill lean and obese patients enrolled at 11 sites in Canada, the United States of America, Belgium and France in order to:
Specific Aims
- Confirm that we can achieve a clinically significant difference in calorie and protein intake between the two intervention groups.
- Estimate recruitment rate i.e. number of eligible and enrolled patients per month per site.
Evaluate the safety, tolerance, and logistics around providing supplemental PN in the study population in the context of a multicenter trial, e.g.
- To ensure adequate glycemic control in both groups.
- To ensure that the other metabolic consequences of the feeding strategies are minimized.
- To establish adequate compliance with study protocols and completion of case report forms
A secondary aim of this pilot study will be:
• To explore the effect of differential effects of calorie and protein delivery on muscle and mass function.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background
Critically ill patients are often hypermetabolic and can rapidly become nutritionally compromised. Malnutrition is prevalent in these patients and has been associated with increased morbidity and mortality. Standard nutrition therapy, i.e. provision of calories, protein and other nutrients consists primarily of enteral nutrition (via a feeding tube into the gastrointestinal tract), parenteral nutrition (via an intravenous tube into the blood), or occasionally a combination of both.
However, the provision of nutrition is sub-optimal and the majority of critically-ill patients do not meet nutritional requirements. Recent studies report that average energy intakes of critically ill patients are only 49% to 70% of calculated requirements. Despite repeated, sustained efforts over the past few years, the investigators have not significantly improved the amount of calories delivered via the enteral route. This leads us to conclude that if the investigators are to be successful at increasing the provision of calories and protein to patients at-risk, the investigators will have to supplement the calories via the parenteral route.
Critically ill patients that are at extremes of weight are at a higher nutritional risk and have higher mortality rates. A recent International multicenter observational study of 2772 ICU patients from 165 ICUs showed a significant inverse linear relationship between the odds of mortality and total daily calories received. Increased amounts of calories was most important for the BMI < 20 group followed by the BMI 20 -< 25 group and BMI > 35 group with no benefit of increased calorie intake for patients in the BMI 25 -< 35 group. Feeding an additional 1000 kcals almost halved the odds of 60-day mortality in patients with a BMI < 25 or > 35. Similar results were observed for feeding an additional 30 grams of protein per day.
Thus, a prospective randomized trial is warranted to confirm our hypothesis that in patients with a BMI of < 25 and those with a BMI > 35 increasing the provision of more energy and protein can impact clinical outcomes. The results of this study will serve to answer some fundamental questions with regards to impact of amount of energy and protein delivered to nutritional at-risk ICU patients and will inform current practice.
Study Intervention:
Patients will be randomized to one of 2 interventions: enteral nutrition alone or enteral nutrition plus parenteral nutrition (supplemental PN group).
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Brussels, Belgium, B - 1070
- Erasme University Hospital
-
-
-
-
Alberta
-
Edmonton, Alberta, Canada, T5H 3V9
- Royal Alexandra Hospital
-
Edmonton, Alberta, Canada, T6L 5X8
- Grey Nuns Hospital
-
Edmonton, Alberta, Canada, T5H 3V9
- University of Alberta
-
-
-
-
-
Strasbourg, France, F - 67091
- Nouvel Hopital Civil
-
-
-
-
Colorado
-
Boulder, Colorado, United States, 80045
- University of Colorado DHSC
-
-
Missouri
-
Saint Louis, Missouri, United States, 63141
- Mercy Hospital St. Louis
-
Saint Louis, Missouri, United States, 63110-1093
- Washington University School of Medicine in St. Louis
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic Lerner College of Medicine
-
Columbus, Ohio, United States, 43221
- The Ohio State Univsersity Medical Center
-
-
Oregon
-
Portland, Oregon, United States, 97239-3098
- Oregon Health & Science University
-
-
Texas
-
Houston, Texas, United States, 77030
- University of Texas Health Science Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Critically ill adult patient (≥ 18 years) admitted to ICU
- Has acute respiratory failure (ARF) i.e. expected to remain mechanically ventilated for more than 48 hours
- Expected ICU dependency of 5 or more days
- On or expected to initiate enteral nutrition within 7 days of ICU admission
- BMI <25 or ≥ 35 based on pre-ICU actual or estimated dry weight
Exclusion Criteria:
- >72 hours from admission to ICU to time of consent
- Not expected to survive an additional 48 hrs from screening evaluation
- A lack of commitment to full aggressive care (anticipated withholding or withdrawing treatments in the first week but isolated DNR acceptable)
- Patients already receiving PN at screening
Absence of All gastrointestinal risk factors, defined as:
- High Apache II Score (>20)
- On more than 1 vasopressor or increasing doses or vasopressors
- Receiving continuous infusion of narcotics
- High nasogastric/orogastric output (>500 mL over 24 hours)
- Recent surgery involving esophagus, stomach, or small bowel OR peritoneal contamination with bowel contents
- Pancreatitis
- Multiple gastrointestinal investigations
- Recent history of diarrhea/C. Difficile
- Surgical patients with future surgeries planned
- Ruptured or dissected abdominal aortic aneurysm
- Patients admitted with diabetic ketoacidosis or non-ketotic hyperosmolar coma
- Pregnant or lactating patients
- Patients with clinical fulminant hepatic failure
- Patients with Cirrhosis Child's Class C Liver Disease (except those on a transplant list or transplantable)
- Dedicated port of central line not available
- Known allergy to study nutrients (soy, eggs or olive products)
- Enrolment in another industry sponsored ICU intervention study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Enteral Nutrition + Parenteral Nutrition
Enteral nutrition with the addition of parenteral supplementation (Olimel 5.7%E/N9E).
|
OLIMEL(Amino Acids, Dextrose, Lipids, with / without Electrolytes) is indicated for parenteral nutrition for adults when oral or enteral nutrition is impossible, insufficient or contraindicated.
Other Names:
|
No Intervention: Enteral Nutrition Only
Enteral nutrition only - no intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Calorie & Protein Intake 7 Days Post Randomization
Time Frame: 7 days post randomization
|
Amount of calories & protein received as a percentage of prescribed.
|
7 days post randomization
|
Calorie & Protein Intake in First 27 Days
Time Frame: first 27 days
|
Amount of calories & protein received as a percentage of prescribed.
|
first 27 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
6 Month Mortality
Time Frame: 6 months
|
Kaplan-Meier estimate.
|
6 months
|
ICU Mortality
Time Frame: 6 months
|
6 months
|
|
Hospital Mortality
Time Frame: 6 months
|
6 months
|
|
Duration of ICU Stay
Time Frame: 6 months
|
6 months
|
|
Duration of Hospital Stay
Time Frame: 6 months
|
6 months
|
|
Duration of Mechanical Ventilation
Time Frame: 6 months
|
6 months
|
|
Development of ICU-acquired Infections
Time Frame: ICU discharge
|
ICU discharge
|
|
SF36-Physical Functioning Domain
Time Frame: 3 months
|
The SF-36 physical function domain ranges from 0-100.
Higher scores indicate better outcome.
|
3 months
|
SF-36 Physical Functioning Domain
Time Frame: 6 months
|
The SF-36 physical function domain ranges from 0-100.
Higher scores indicate better outcome.
|
6 months
|
Functional Status at Hospital Discharge
Time Frame: hospital discharge
|
hospital discharge
|
|
SF36 Role Physical Domain
Time Frame: 3 months
|
The SF-36 role physical function domain ranges from 0-100.
Higher scores indicate better outcome.
|
3 months
|
SF36 Pain Index Domain
Time Frame: 3 months
|
The SF-36 pain index domain ranges from 0-100.
Higher scores indicate better outcome.
|
3 months
|
SF36 General Health Perceptions Domain
Time Frame: 3 months
|
The SF-36 general health perceptions domain ranges from 0-100.
Higher scores indicate better outcome.
|
3 months
|
SF36 Vitality Domain
Time Frame: 3 months
|
The SF-36 vitality domain ranges from 0-100.
Higher scores indicate better outcome.
|
3 months
|
SF36 Social Functioning Domain
Time Frame: 3 months
|
The SF-36 social functioning domain ranges from 0-100.
Higher scores indicate better outcome.
|
3 months
|
SF36 Role-emotional Domain
Time Frame: 3 months
|
The SF-36 role-emotion domain ranges from 0-100.
Higher scores indicate better outcome.
|
3 months
|
SF36 Mental Health Index Domain
Time Frame: 3 months
|
The SF-36 mental health index domain ranges from 0-100.
Higher scores indicate better outcome.
|
3 months
|
SF36 Standardized Physical Component Scale
Time Frame: 3 months
|
The SF36 Standardized Physical Component Scale has been scaled to have a mean of zero and standard deviation of 10 in a general US population.
Higher scores indicate better HRQoL.
|
3 months
|
SF36 Standardized Mental Component Scale
Time Frame: 3 months
|
The SF36 Standardized Mental Component Scale has been scaled to have a mean of zero and standard deviation of 10 in a general US population.
Higher scores indicate better HRQoL.
|
3 months
|
SF-36 Role-physical Domain
Time Frame: 6 months
|
The SF-36 mental health index domain ranges from 0-100.
Higher scores indicate better outcome.
|
6 months
|
SF-36 Pain Index Domain
Time Frame: 6 months
|
The SF-36 mental health index domain ranges from 0-100.
Higher scores indicate better outcome.
|
6 months
|
SF-36 General Health Perceptions Domain
Time Frame: 6 months
|
The SF-36 general health perceptions domain ranges from 0-100.
Higher scores indicate better outcome.
|
6 months
|
SF-36 Vitality Domain
Time Frame: 6 months
|
The SF-36 vitality domain ranges from 0-100.
Higher scores indicate better outcome.
|
6 months
|
SF-36 Social Functioning Domain
Time Frame: 6 months
|
The SF-36 social functioning domain ranges from 0-100.
Higher scores indicate better outcome.
|
6 months
|
SF-36 Role-emotional Domain
Time Frame: 6 months
|
The SF-36 role-emotional domain ranges from 0-100.
Higher scores indicate better outcome.
|
6 months
|
SF-36 Mental Health Index Domain
Time Frame: 6 months
|
The SF-36 mental health index domain ranges from 0-100.
Higher scores indicate better outcome.
|
6 months
|
SF-36 Standardized Physical Component Scale
Time Frame: 6 months
|
The SF36 Standardized Physical Component Scale has been scaled to have a mean of zero and standard deviation of 10 in a general US population.
Higher scores indicate better HRQoL.
|
6 months
|
SF-36 Standardized Mental Component Scale
Time Frame: 6 months
|
The SF36 Standardized mental Component Scale has been scaled to have a mean of zero and standard deviation of 10 in a general US population.
Higher scores indicate better HRQoL.
|
6 months
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Daren K. Heyland, MD, Clinical Evaluation Research Unit, Kingston General Hospital
Publications and helpful links
General Publications
- Alberda C, Gramlich L, Jones N, Jeejeebhoy K, Day AG, Dhaliwal R, Heyland DK. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med. 2009 Oct;35(10):1728-37. doi: 10.1007/s00134-009-1567-4. Epub 2009 Jul 2. Erratum In: Intensive Care Med. 2009 Oct;35(10):1821.
- Villet S, Chiolero RL, Bollmann MD, Revelly JP, Cayeux R N MC, Delarue J, Berger MM. Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr. 2005 Aug;24(4):502-9. doi: 10.1016/j.clnu.2005.03.006.
- Krishnan JA, Parce PB, Martinez A, Diette GB, Brower RG. Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Chest. 2003 Jul;124(1):297-305. doi: 10.1378/chest.124.1.297.
- Hise ME, Halterman K, Gajewski BJ, Parkhurst M, Moncure M, Brown JC. Feeding practices of severely ill intensive care unit patients: an evaluation of energy sources and clinical outcomes. J Am Diet Assoc. 2007 Mar;107(3):458-65. doi: 10.1016/j.jada.2006.12.012.
- Dhaliwal R, Jurewitsch B, Harrietha D, Heyland DK. Combination enteral and parenteral nutrition in critically ill patients: harmful or beneficial? A systematic review of the evidence. Intensive Care Med. 2004 Aug;30(8):1666-71. doi: 10.1007/s00134-004-2345-y. Epub 2004 Jun 8.
- Wischmeyer PE, Hasselmann M, Kummerlen C, Kozar R, Kutsogiannis DJ, Karvellas CJ, Besecker B, Evans DK, Preiser JC, Gramlich L, Jeejeebhoy K, Dhaliwal R, Jiang X, Day AG, Heyland DK. A randomized trial of supplemental parenteral nutrition in underweight and overweight critically ill patients: the TOP-UP pilot trial. Crit Care. 2017 Jun 9;21(1):142. doi: 10.1186/s13054-017-1736-8.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TOP-UP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Boston Children's HospitalCompleted
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Hospital de Clinicas de Porto AlegreUnknownCritical Illness PolyneuropathiesBrazil
-
Peking Union Medical College HospitalBaxter Healthcare CorporationUnknownNutrition Therapy for Critical Illness
-
Assistance Publique - Hôpitaux de ParisRecruitingCritical Illness Related Corticosteroids InsufficiencyFrance
-
Yuzuncu Yıl UniversityKahramanmaras Sutcu Imam University; Izmir Ataturk Training and Research HospitalCompleted
Clinical Trials on Olimel (5.7%E / N9E)
-
King Faisal Specialist Hospital & Research CenterCompletedHyperphosphatemia | Hyperkalemia | Hypercalcemia | HypermagnesemiaSaudi Arabia
-
Fresenius KabiTerminatedCritical IllnessFrance, Germany, Poland
-
RWTH Aachen UniversityClinical Evaluation Research Unit at Kingston General HospitalWithdrawnCritical Illness | Malnutrition | Frailty | Sarcopenia | Nutritional DisorderGermany
-
University of AlbertaBaxter Healthcare CorporationRecruitingMalnutrition | SurgeryCanada
-
Lawson Health Research InstituteAcademic Medical Organization of Southwestern OntarioCompleted